BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18489166)

  • 1. Chemistry, biology, and medicinal potential of narciclasine and its congeners.
    Kornienko A; Evidente A
    Chem Rev; 2008 Jun; 108(6):1982-2014. PubMed ID: 18489166
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological evaluation of ent-narciclasine, ent-lycoricidine, and certain enantiomerically-related congeners.
    Matveenko M; Banwell MG; Joffe M; Wan S; Fantino E
    Chem Biodivers; 2009 May; 6(5):685-91. PubMed ID: 19479847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Amaryllidaceae Constituents and Unnatural Derivatives.
    Ghavre M; Froese J; Pour M; Hudlicky T
    Angew Chem Int Ed Engl; 2016 May; 55(19):5642-91. PubMed ID: 26969844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of unnatural derivatives of narciclasine: 7-aza-nornarciclasine and its N-oxide.
    Vshyvenko S; Reisenauer MR; Rogelj S; Hudlicky T
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4236-8. PubMed ID: 25108300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive montanine derivatives from halide-induced rearrangements of haemanthamine-type alkaloids. Absolute configuration by VCD.
    Cedrón JC; Estévez-Braun A; Ravelo AG; Gutiérrez D; Flores N; Bucio MA; Pérez-Hernández N; Joseph-Nathan P
    Org Lett; 2009 Apr; 11(7):1491-4. PubMed ID: 19320502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents.
    Ingrassia L; Lefranc F; Dewelle J; Pottier L; Mathieu V; Spiegl-Kreinecker S; Sauvage S; El Yazidi M; Dehoux M; Berger W; Van Quaquebeke E; Kiss R
    J Med Chem; 2009 Feb; 52(4):1100-14. PubMed ID: 19199649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells.
    Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A
    Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of C-1 homologues of pancratistatin and their preliminary biological evaluation.
    Vshyvenko S; Scattolon J; Hudlicky T; Romero AE; Kornienko A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4750-2. PubMed ID: 21757350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antineoplastic agents. 587. Isolation and structure of 3-epipancratistatin from Narcissus cv. Ice Follies.
    Pettit GR; Tan R; Bao GH; Melody N; Doubek DL; Gao S; Chapuis JC; Williams L
    J Nat Prod; 2012 Apr; 75(4):771-3. PubMed ID: 22413911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties.
    Fürst R
    Planta Med; 2016 Nov; 82(16):1389-1394. PubMed ID: 27542176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Narciclasine-4-
    Katoch D; Kumar D; Padwad YS; Singh B; Sharma U
    Nat Prod Res; 2020 Jan; 34(2):233-240. PubMed ID: 30636443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lycorine and its derivatives for anticancer drug design.
    Lamoral-Theys D; Decaestecker C; Mathieu V; Dubois J; Kornienko A; Kiss R; Evidente A; Pottier L
    Mini Rev Med Chem; 2010 Jan; 10(1):41-50. PubMed ID: 20105122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of anti-HCV activity and SAR study of (+)-lycoricidine through targeting of host heat-stress cognate 70 (Hsc70).
    Chen DZ; Jiang JD; Zhang KQ; He HP; Di YT; Zhang Y; Cai JY; Wang L; Li SL; Yi P; Peng ZG; Hao XJ
    Bioorg Med Chem Lett; 2013 May; 23(9):2679-82. PubMed ID: 23511018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives.
    Hudlicky T; Rinner U; Gonzalez D; Akgun H; Schilling S; Siengalewicz P; Martinot TA; Pettit GR
    J Org Chem; 2002 Dec; 67(25):8726-43. PubMed ID: 12467383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore.
    McNulty J; Larichev V; Pandey S
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5315-8. PubMed ID: 16183280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues.
    McNulty J; Nair JJ; Griffin C; Pandey S
    J Nat Prod; 2008 Mar; 71(3):357-63. PubMed ID: 18225861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids.
    McNulty J; Nair JJ; Singh M; Crankshaw DJ; Holloway AC; Bastida J
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3233-7. PubMed ID: 19428250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total Synthesis of Lycoricidine and Narciclasine by Chemical Dearomatization of Bromobenzene.
    Southgate EH; Holycross DR; Sarlah D
    Angew Chem Int Ed Engl; 2017 Nov; 56(47):15049-15052. PubMed ID: 29024240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Chemical Synthesis of the Crinine and Haemanthamine Alkaloids: Biologically Active and Enantiomerically-Related Systems that Serve as Vehicles for Showcasing New Methodologies for Molecular Assembly.
    Hu N; White LV; Lan P; Banwell MG
    Molecules; 2021 Feb; 26(3):. PubMed ID: 33540725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay(1a).
    Pettit GR; Melody N; Herald DL
    J Org Chem; 2001 Apr; 66(8):2583-7. PubMed ID: 11304174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.